Logo image of ACX.DE

BET-AT-HOME.COM AG (ACX.DE) Stock Fundamental Analysis

FRA:ACX - Deutsche Boerse Ag - DE000A0DNAY5 - Common Stock - Currency: EUR

3.01  +0.07 (+2.38%)

Fundamental Rating

3

Taking everything into account, ACX scores 3 out of 10 in our fundamental rating. ACX was compared to 56 industry peers in the Hotels, Restaurants & Leisure industry. While ACX has a great health rating, there are worries on its profitability. ACX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ACX has reported negative net income.
ACX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACX reported negative net income in multiple years.
ACX had a positive operating cash flow in 4 of the past 5 years.
ACX.DE Yearly Net Income VS EBIT VS OCF VS FCFACX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

With a Return On Assets value of -15.13%, ACX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
ACX has a Return On Equity of -34.67%. This is in the lower half of the industry: ACX underperforms 60.00% of its industry peers.
Industry RankSector Rank
ROA -15.13%
ROE -34.67%
ROIC N/A
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ACX.DE Yearly ROA, ROE, ROICACX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

In the last couple of years the Operating Margin of ACX has declined.
ACX has a Gross Margin of 78.97%. This is amongst the best in the industry. ACX outperforms 83.33% of its industry peers.
ACX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ACX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.97%
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
ACX.DE Yearly Profit, Operating, Gross MarginsACX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

7

2. Health

2.1 Basic Checks

ACX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACX remains at a similar level compared to 1 year ago.
The number of shares outstanding for ACX remains at a similar level compared to 5 years ago.
ACX has a better debt/assets ratio than last year.
ACX.DE Yearly Shares OutstandingACX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ACX.DE Yearly Total Debt VS Total AssetsACX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

ACX has an Altman-Z score of 2.23. This is not the best score and indicates that ACX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.23, ACX is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
The Debt to FCF ratio of ACX is 1.85, which is an excellent value as it means it would take ACX, only 1.85 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ACX (1.85) is better than 86.67% of its industry peers.
ACX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
ACX has a better Debt to Equity ratio (0.05) than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.85
Altman-Z 2.23
ROIC/WACCN/A
WACC6.9%
ACX.DE Yearly LT Debt VS Equity VS FCFACX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ACX has a Current Ratio of 1.51. This is a normal value and indicates that ACX is financially healthy and should not expect problems in meeting its short term obligations.
ACX has a better Current ratio (1.51) than 86.67% of its industry peers.
A Quick Ratio of 1.51 indicates that ACX should not have too much problems paying its short term obligations.
The Quick ratio of ACX (1.51) is better than 88.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
ACX.DE Yearly Current Assets VS Current LiabilitesACX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The earnings per share for ACX have decreased strongly by -167.31% in the last year.
ACX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.37%.
ACX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -18.26% yearly.
EPS 1Y (TTM)-167.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.78%
Revenue 1Y (TTM)14.37%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%15.21%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACX.DE Yearly Revenue VS EstimatesACX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
ACX.DE Yearly EPS VS EstimatesACX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACX. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.81, which indicates a rather cheap valuation of ACX.
Based on the Price/Forward Earnings ratio, ACX is valued cheaper than 98.33% of the companies in the same industry.
ACX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.81
ACX.DE Price Earnings VS Forward Price EarningsACX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

ACX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.73
EV/EBITDA N/A
ACX.DE Per share dataACX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ACX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACX!.
Industry RankSector Rank
Dividend Yield N/A

BET-AT-HOME.COM AG

FRA:ACX (5/30/2025, 7:00:00 PM)

3.01

+0.07 (+2.38%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-14 2025-05-14
Earnings (Next)07-29 2025-07-29
Inst Owners0.31%
Inst Owner ChangeN/A
Ins Owners58.83%
Ins Owner ChangeN/A
Market Cap21.13M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.81
P/S 0.28
P/FCF 27.73
P/OCF 26.68
P/B 0.92
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)0.63
Fwd EY20.8%
FCF(TTM)0.11
FCFY3.61%
OCF(TTM)0.11
OCFY3.75%
SpS10.86
BVpS3.28
TBVpS3.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.13%
ROE -34.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.97%
FCFM 1%
ROA(3y)2.63%
ROA(5y)2.17%
ROE(3y)5.43%
ROE(5y)-6.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-58.22%
OM growth 5Y-42.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y-0.6%
F-Score5
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.85
Debt/EBITDA N/A
Cap/Depr 2.37%
Cap/Sales 0.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 2.23
F-Score5
WACC6.9%
ROIC/WACCN/A
Cap/Depr(3y)22.88%
Cap/Depr(5y)42.26%
Cap/Sales(3y)0.89%
Cap/Sales(5y)1.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-167.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.78%
EPS Next Y24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.37%
Revenue growth 3Y-4.13%
Revenue growth 5Y-18.26%
Sales Q2Q%15.21%
Revenue Next Year7.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.43%
EBIT growth 3Y-59.94%
EBIT growth 5Y-53.14%
EBIT Next Year80%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y371.17%
FCF growth 3Y-55.42%
FCF growth 5Y-51.16%
OCF growth 1Y661.54%
OCF growth 3Y-57.74%
OCF growth 5Y-51.62%